Nanoemulsões do extrato do cálice de Physalis peruviana: desenvolvimento, avaliação da estabilidade e estudos de toxicidade

Detalhes bibliográficos
Ano de defesa: 2019
Autor(a) principal: Bazana, Maiara Taís
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
dARK ID: ark:/26339/0013000014bk7
Idioma: por
Instituição de defesa: Universidade Federal de Santa Maria
Brasil
Ciência e Tecnologia dos Alimentos
UFSM
Programa de Pós-Graduação em Ciência e Tecnologia dos Alimentos
Centro de Ciências Rurais
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: http://repositorio.ufsm.br/handle/1/22952
Resumo: Physalis peruviana presents a variety of biologically active compounds, especially in its calyx, which is considered a byproduct with potential to be explored and reused. Among the most promising technologies in the food industry, nanotechnology stands out with its ability to encapsulate various compounds, which have limitations. However, this technology still requires further studies on the nanotoxicity of formulations and its use in waste generated by industries. Therefore, the objective of this study was to develop nanoemulsions containing the P. peruviana calyx extract and evaluate the stability of the extract and nanoemulsions against different storage conditions, antioxidant capacity, and in vitro and in vivo toxicity, aiming its application in food. The extracts were prepared in 60% ethanol and characterized by antioxidant capacity, reducing capacity, HPLC-quantified major compound, antibacterial activity, and antibiofilm capacity. Nanoemulsions were prepared by the spontaneous emulsification method and physically and chemically characterized. Afterwards, the stability of the extracts and nanoemulsions were evaluated under different storage conditions, such as temperatures of 7 and 25 °C with the absence or incidence of light for 120 days. Additionally, the release of the major compound from the nanoemulsions and extract in a simulated gastrointestinal environment, the in vitro toxicity in tumor cell lines (MCF-7 breast cancer) and non-tumor cell lines (3T3 fibroblasts), and in vivo (using the Caenorhabditis elegans model) were evaluated. The P. peruviana calyx extract was characterized by its reducing capacity (610 mg Eq. of gallic acid/100 g of calyx), antioxidant capacity (138 μmol Trolox/g of calyx), and rutin content (11.3 μg/mL). The minimum inhibitory concentration ranged from 3.15 to 30 mg/mL extract, showing bacteriostatic activity against eight pathogens and bactericidal activity at 30 mg/mL concentration against six strains. Nevertheless, the extract inhibited the formation of biofilm produced by Pseudomonas aeruginosa PA01, although there was no destruction. The nanoemulsions had nanometric droplet size (160-180 nm), polydispersity index below 0.15, zeta potential (-8 to -11 mV), slightly acidic pH (5.4 to 6.3), droplets (unimodal peak in the nanometer range), morphology (spherical shape and smooth surface), rutin content (11 μg/mL), and encapsulation efficiency of 85%. Among the tested samples, the highest stability was observed in nanoemulsions containing the P. peruviana calyx extract when stored at room temperature and in the absence of light. The extract and nanoemulsions of the extract showed no toxicity in the non-tumor cell line. However, as the concentration of nanoemulsions increased, they demonstrated cytotoxicity against the tumor cell line. In the in vivo model, all samples analyzed did not cause toxicity to C. elegans in the survival test. Regarding resistance to oxidative stress, the formulations exerted their antioxidant effects at low concentrations in vivo. In addition, the rutin present in the nanoemulsion extract showed greater stability against the degradation of simulated gastrointestinal conditions compared to the free extract, controlling the release and increasing the levels of bioactive compounds released in the duodenum and ileum, which is where absorption occurs. Therefore, this study contributes to future applications in the food area to be studied and deepened.
id UFSM_35311086f845336ca834d608fb81376e
oai_identifier_str oai:repositorio.ufsm.br:1/22952
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Nanoemulsões do extrato do cálice de Physalis peruviana: desenvolvimento, avaliação da estabilidade e estudos de toxicidadeNanoemulsions of the Physalis peruviana calyx extract: development, stability assessment, and toxicity studiesCape gooseberryC. elegansCytotoxicityC. elegansNanotechnologyResidueCitotoxicidadeNanotecnologiaResíduoCNPQ::CIENCIAS AGRARIAS::CIENCIA E TECNOLOGIA DE ALIMENTOSPhysalis peruviana presents a variety of biologically active compounds, especially in its calyx, which is considered a byproduct with potential to be explored and reused. Among the most promising technologies in the food industry, nanotechnology stands out with its ability to encapsulate various compounds, which have limitations. However, this technology still requires further studies on the nanotoxicity of formulations and its use in waste generated by industries. Therefore, the objective of this study was to develop nanoemulsions containing the P. peruviana calyx extract and evaluate the stability of the extract and nanoemulsions against different storage conditions, antioxidant capacity, and in vitro and in vivo toxicity, aiming its application in food. The extracts were prepared in 60% ethanol and characterized by antioxidant capacity, reducing capacity, HPLC-quantified major compound, antibacterial activity, and antibiofilm capacity. Nanoemulsions were prepared by the spontaneous emulsification method and physically and chemically characterized. Afterwards, the stability of the extracts and nanoemulsions were evaluated under different storage conditions, such as temperatures of 7 and 25 °C with the absence or incidence of light for 120 days. Additionally, the release of the major compound from the nanoemulsions and extract in a simulated gastrointestinal environment, the in vitro toxicity in tumor cell lines (MCF-7 breast cancer) and non-tumor cell lines (3T3 fibroblasts), and in vivo (using the Caenorhabditis elegans model) were evaluated. The P. peruviana calyx extract was characterized by its reducing capacity (610 mg Eq. of gallic acid/100 g of calyx), antioxidant capacity (138 μmol Trolox/g of calyx), and rutin content (11.3 μg/mL). The minimum inhibitory concentration ranged from 3.15 to 30 mg/mL extract, showing bacteriostatic activity against eight pathogens and bactericidal activity at 30 mg/mL concentration against six strains. Nevertheless, the extract inhibited the formation of biofilm produced by Pseudomonas aeruginosa PA01, although there was no destruction. The nanoemulsions had nanometric droplet size (160-180 nm), polydispersity index below 0.15, zeta potential (-8 to -11 mV), slightly acidic pH (5.4 to 6.3), droplets (unimodal peak in the nanometer range), morphology (spherical shape and smooth surface), rutin content (11 μg/mL), and encapsulation efficiency of 85%. Among the tested samples, the highest stability was observed in nanoemulsions containing the P. peruviana calyx extract when stored at room temperature and in the absence of light. The extract and nanoemulsions of the extract showed no toxicity in the non-tumor cell line. However, as the concentration of nanoemulsions increased, they demonstrated cytotoxicity against the tumor cell line. In the in vivo model, all samples analyzed did not cause toxicity to C. elegans in the survival test. Regarding resistance to oxidative stress, the formulations exerted their antioxidant effects at low concentrations in vivo. In addition, the rutin present in the nanoemulsion extract showed greater stability against the degradation of simulated gastrointestinal conditions compared to the free extract, controlling the release and increasing the levels of bioactive compounds released in the duodenum and ileum, which is where absorption occurs. Therefore, this study contributes to future applications in the food area to be studied and deepened.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESA Physalis peruviana apresenta uma variedade de compostos biologicamente ativos principalmente em seu cálice, o qual é considerado um subproduto, com potencial para ser explorado e reutilizado. Entre as tecnologias mais promissoras na indústria de alimentos, destaca-se a nanotecnologia, com a capacidade de encapsular variados compostos que possuem limitações. No entanto, ainda requer maiores estudos quanto à nanotoxicologia das formulações e sua aplicação em resíduos gerados pelas indústrias. Nesse sentido, o objetivo deste trabalho consistiu em desenvolver nanoemulsões contendo o extrato do cálice de P. peruviana e avaliar a estabilidade do extrato e das nanoemulsões frente a diferentes condições de armazenamento, capacidade antioxidante, e toxicidade in vitro e in vivo, visando sua aplicação em alimentos. Os extratos foram preparados em etanol 60% e caracterizados quanto à capacidade antioxidante, capacidade redutora, composto majoritário, atividade antibacteriana e capacidade antibiofilme. As nanoemulsões foram preparadas pelo método de emulsificação espontânea e caracterizadas físico-quimicamente. Após, avaliou-se a estabilidade dos extratos e das nanoemulsões frente a diferentes condições de armazenamento, tais como temperaturas de 7 e 25°C com ausência ou incidência de luz por 120 dias. Também, verificou-se: a liberação do composto majoritário a partir das nanoemulsões e do extrato em meio gastrointestinal simulado; a toxicidade in vitro em linhagens de células tumorais (MCF-7 câncer de mama) e não tumorais (3T3 fibroblastos) e in vivo (utilizando o modelo Caenorhabditis elegans). O extrato do cálice de P. peruviana foi caracterizado quanto a sua capacidade redutora (610 mg Eq. de ácido gálico/100 g de cálice), capacidade antioxidante (138 μmol de Trolox/g de cálice) e teor de rutina (11,3 μg/mL). A concentração inibitória mínima variou de 3,15 a 30 mg/mL de extrato, demonstrando atividade bacteriostática frente a oito patógenos e atividade bactericida na concentração de 30 mg/mL frente a seis cepas. Ainda, o extrato inibiu a formação de biofilme produzido pela Pseudomonas aeruginosa PA01, porém não houve destruição. As nanoemulsões apresentaram tamanho de gotícula nanométrico (160-180 nm), índice de polidispersão abaixo de 0,15, potencial zeta (-8 a -11 mV), pH levemente ácido (5,4 a 6,3), distribuição do tamanho de gotículas (pico unimodal na faixa nanométrica), morfologia (formato esférico e superfície lisa), teor de rutina (11 μg/mL) e eficiência de encapsulamento de 85%. Entre as amostras testadas, a maior estabilidade foi observada para as nanoemulsões contendo o extrato do cálice de P. peruviana quando armazenadas à temperatura ambiente e com ausência de luz. O extrato e as nanoemulsões do extrato não mostraram toxicidade na linhagem celular não tumoral. No entanto, à medida que a concentração das nanoemulsões aumentou, elas demonstraram citotoxicidade contra a linhagem celular tumoral. No modelo in vivo, todas as amostras analisadas não causaram toxicidade para C. elegans no teste de sobrevivência. Em relação à resistência ao estresse oxidativo, as formulações exerceram seus efeitos antioxidantes em baixas concentrações in vivo. Além disso, a rutina presente no extrato nanoemulsionado apresentou maior estabilidade frente às condições gastrointestinais simuladas em relação a presente no extrato livre, controlando a liberação e aumentando os níveis de bioativo liberado no duodeno e íleo, onde ocorre a absorção. Portanto, este estudo contribui para que futuras aplicações na área de alimentos sejam estudadas e aprofundadas.Universidade Federal de Santa MariaBrasilCiência e Tecnologia dos AlimentosUFSMPrograma de Pós-Graduação em Ciência e Tecnologia dos AlimentosCentro de Ciências RuraisMenezes, Cristiano Ragagnin dehttp://lattes.cnpq.br/1755735245826251Silva, Cristiane de Bona daOurique, Aline FerreiraCodevilla, Cristiane FrancoBallus, Cristiano AugustoSomacal, SabrinaBazana, Maiara Taís2021-11-24T14:04:38Z2021-11-24T14:04:38Z2019-10-18info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/22952ark:/26339/0013000014bk7porAttribution-NonCommercial-NoDerivatives 4.0 Internationalinfo:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2021-11-25T06:03:25Zoai:repositorio.ufsm.br:1/22952Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/PUBhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.com||manancial@ufsm.bropendoar:2021-11-25T06:03:25Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Nanoemulsões do extrato do cálice de Physalis peruviana: desenvolvimento, avaliação da estabilidade e estudos de toxicidade
Nanoemulsions of the Physalis peruviana calyx extract: development, stability assessment, and toxicity studies
title Nanoemulsões do extrato do cálice de Physalis peruviana: desenvolvimento, avaliação da estabilidade e estudos de toxicidade
spellingShingle Nanoemulsões do extrato do cálice de Physalis peruviana: desenvolvimento, avaliação da estabilidade e estudos de toxicidade
Bazana, Maiara Taís
Cape gooseberry
C. elegans
Cytotoxicity
C. elegans
Nanotechnology
Residue
Citotoxicidade
Nanotecnologia
Resíduo
CNPQ::CIENCIAS AGRARIAS::CIENCIA E TECNOLOGIA DE ALIMENTOS
title_short Nanoemulsões do extrato do cálice de Physalis peruviana: desenvolvimento, avaliação da estabilidade e estudos de toxicidade
title_full Nanoemulsões do extrato do cálice de Physalis peruviana: desenvolvimento, avaliação da estabilidade e estudos de toxicidade
title_fullStr Nanoemulsões do extrato do cálice de Physalis peruviana: desenvolvimento, avaliação da estabilidade e estudos de toxicidade
title_full_unstemmed Nanoemulsões do extrato do cálice de Physalis peruviana: desenvolvimento, avaliação da estabilidade e estudos de toxicidade
title_sort Nanoemulsões do extrato do cálice de Physalis peruviana: desenvolvimento, avaliação da estabilidade e estudos de toxicidade
author Bazana, Maiara Taís
author_facet Bazana, Maiara Taís
author_role author
dc.contributor.none.fl_str_mv Menezes, Cristiano Ragagnin de
http://lattes.cnpq.br/1755735245826251
Silva, Cristiane de Bona da
Ourique, Aline Ferreira
Codevilla, Cristiane Franco
Ballus, Cristiano Augusto
Somacal, Sabrina
dc.contributor.author.fl_str_mv Bazana, Maiara Taís
dc.subject.por.fl_str_mv Cape gooseberry
C. elegans
Cytotoxicity
C. elegans
Nanotechnology
Residue
Citotoxicidade
Nanotecnologia
Resíduo
CNPQ::CIENCIAS AGRARIAS::CIENCIA E TECNOLOGIA DE ALIMENTOS
topic Cape gooseberry
C. elegans
Cytotoxicity
C. elegans
Nanotechnology
Residue
Citotoxicidade
Nanotecnologia
Resíduo
CNPQ::CIENCIAS AGRARIAS::CIENCIA E TECNOLOGIA DE ALIMENTOS
description Physalis peruviana presents a variety of biologically active compounds, especially in its calyx, which is considered a byproduct with potential to be explored and reused. Among the most promising technologies in the food industry, nanotechnology stands out with its ability to encapsulate various compounds, which have limitations. However, this technology still requires further studies on the nanotoxicity of formulations and its use in waste generated by industries. Therefore, the objective of this study was to develop nanoemulsions containing the P. peruviana calyx extract and evaluate the stability of the extract and nanoemulsions against different storage conditions, antioxidant capacity, and in vitro and in vivo toxicity, aiming its application in food. The extracts were prepared in 60% ethanol and characterized by antioxidant capacity, reducing capacity, HPLC-quantified major compound, antibacterial activity, and antibiofilm capacity. Nanoemulsions were prepared by the spontaneous emulsification method and physically and chemically characterized. Afterwards, the stability of the extracts and nanoemulsions were evaluated under different storage conditions, such as temperatures of 7 and 25 °C with the absence or incidence of light for 120 days. Additionally, the release of the major compound from the nanoemulsions and extract in a simulated gastrointestinal environment, the in vitro toxicity in tumor cell lines (MCF-7 breast cancer) and non-tumor cell lines (3T3 fibroblasts), and in vivo (using the Caenorhabditis elegans model) were evaluated. The P. peruviana calyx extract was characterized by its reducing capacity (610 mg Eq. of gallic acid/100 g of calyx), antioxidant capacity (138 μmol Trolox/g of calyx), and rutin content (11.3 μg/mL). The minimum inhibitory concentration ranged from 3.15 to 30 mg/mL extract, showing bacteriostatic activity against eight pathogens and bactericidal activity at 30 mg/mL concentration against six strains. Nevertheless, the extract inhibited the formation of biofilm produced by Pseudomonas aeruginosa PA01, although there was no destruction. The nanoemulsions had nanometric droplet size (160-180 nm), polydispersity index below 0.15, zeta potential (-8 to -11 mV), slightly acidic pH (5.4 to 6.3), droplets (unimodal peak in the nanometer range), morphology (spherical shape and smooth surface), rutin content (11 μg/mL), and encapsulation efficiency of 85%. Among the tested samples, the highest stability was observed in nanoemulsions containing the P. peruviana calyx extract when stored at room temperature and in the absence of light. The extract and nanoemulsions of the extract showed no toxicity in the non-tumor cell line. However, as the concentration of nanoemulsions increased, they demonstrated cytotoxicity against the tumor cell line. In the in vivo model, all samples analyzed did not cause toxicity to C. elegans in the survival test. Regarding resistance to oxidative stress, the formulations exerted their antioxidant effects at low concentrations in vivo. In addition, the rutin present in the nanoemulsion extract showed greater stability against the degradation of simulated gastrointestinal conditions compared to the free extract, controlling the release and increasing the levels of bioactive compounds released in the duodenum and ileum, which is where absorption occurs. Therefore, this study contributes to future applications in the food area to be studied and deepened.
publishDate 2019
dc.date.none.fl_str_mv 2019-10-18
2021-11-24T14:04:38Z
2021-11-24T14:04:38Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/22952
dc.identifier.dark.fl_str_mv ark:/26339/0013000014bk7
url http://repositorio.ufsm.br/handle/1/22952
identifier_str_mv ark:/26339/0013000014bk7
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Ciência e Tecnologia dos Alimentos
UFSM
Programa de Pós-Graduação em Ciência e Tecnologia dos Alimentos
Centro de Ciências Rurais
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Ciência e Tecnologia dos Alimentos
UFSM
Programa de Pós-Graduação em Ciência e Tecnologia dos Alimentos
Centro de Ciências Rurais
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com||manancial@ufsm.br
_version_ 1847153491743604736